Objectives The purpose of this study is to explore the relationship between the interactions of CYP2C19 gene polymorphisms and several environmental factors and oesophageal squamous cell carcinoma (OSCC). Methods In a case-control study of OSCC patients (n = 350) and healthy controls (n = 350), we investigated the roles of polymorphism in the CYP2C19 gene by the use of polymerase chain reaction - restriction fragment length polymorphism (PCR – RFLP) analysis. Results The CYP2C19*3 AG+AA genotype was significantly more prevalent in OSCC patients (10.0% versus 3.43%; P<0.01). Multiple logistic regression analysis showed drinking (OR: 5.603, 95% CI: 3.431–11.112; P = 0.005) and smoking (OR: 4.341, 95% CI: 3.425–10.241; P = 0.001) was the independent risk factor of OSCC respectively, and there were significant interaction between CYP2C19*3 and drinking (OR: 8.747, 95% CI: 6.321–18.122; P = 0.009). Conclusions The CYP2C19*3 polymorphism and OSCC were synergistically and significantly associated in Chinese Han patients.
References
[1]
Zheng S, Vuitton L, Sheyhidin I, Vuitton DA, Zhang Y, et al. (2011) Northwestern China: a place to learn more on oesophageal cancer. Part two: gene alterations and polymorphisms. Eur J Gastroenterol Hepatol 23: 1087–1099.
[2]
Chen KL, Yin HY, Yi DT, Lan YG, Wu BZ, et al. (1995) The association between smoking, drinking and dietary habit and the incidence of esophageal cancer in low risk area. Bull Chin Cancer 4: 7–9.
[3]
Chen W, Sun XD, Fan JH, Yang ZM, Lian SY (2003) The study for risk factors and changing rule of esophageal cancer in Linxian. Cancer Res Clin 15: 5–7.
[4]
Matejcic M, Li D, Prescott NJ, Lewis CM, Mathew CG, et al. (2011) Association of a Deletion of GSTT2B with an Altered Risk of Oesophageal Squamous Cell Carcinoma in a South African Population: A Case-Control Study. PLoS One 6: e29366.
[5]
Bye H, Prescott NJ, Matejcic M, Rose E, Lewis CM, et al. (2011) Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Carcinogenesis 32: 1855–61.
[6]
Zheng S, Vuitton L, Sheyhidin I, Vuitton DA, Zhang Y, et al. (2010) Northwestern China: a place to learn more on oesophageal cancer. Part one: behavioural and environmental risk factors. Eur J Gastroenterol Hepatol 22: 917–25.
[7]
Tanaka F, Yamamoto K, Suzuki S, Inoue H, Tsurumaru M, et al. (2010) Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut 59: 1457–64.
[8]
Lundell K, Wikvall K (2008) Species-specific and age-dependent bile acid composition: aspects on CYP8B and CYP4A subfamilies in bile acid biosynthesis. Curr Drug Metab 9: 323–331.
[9]
Fava C, Montagnana M, Almgren P (2008) The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure. Hypertension 52: 373–380.
[10]
Node K, Ruan XL, Dai J (2001) Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 276: 15983–15989.
[11]
Fichtlscherer S, Dimmeler S, Breuer S, Busse R, Zeiher AM, et al. (2004) Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease. Circulation 109: 178–183.
[12]
Ercan B, Ayaz L, Ci？ek D, Tamer L (2008) Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. Cell Biochem Funct 26: 309–313.
Isomura Y, Yamaji Y, Ohta M, Seto M, Asaoka Y, et al. (2010) A genetic polymorphism of CYP2C19 is associated with susceptibility to biliary tract cancer. J Gastroenterol 45: 1045–1052.
[15]
Afsar NA, Haenisch S, Mateen A, Usman A, Ufer M, et al. (2010) Genotype frequencies of selected drug metabolizing enzymes and ABC drug transporters among breast cancer patients on FAC chemotherapy. Basic Clin Pharmacol Toxicol 107: 570–6.
[16]
Yadav SS, Ruwali M, Pant MC, Shukla P, Singh RL, et al. (2010) Interaction of drug metabolizing cytochrome P450 2D6 poor metabolizers with cytochrome P450 2C9 and 2C19 genotypes modify the susceptibility to head and neck cancer and treatment response. Mutat Res 684: 49–55.
[17]
Bozina N, Bradamante V, Lovri？ M (2009) Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk. Arh Hig Rada Toksikol 60: 217–42.
[18]
Ercan B, Ayaz L, Ci？ek D, Tamer L (2008) Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. Cell Biochem Funct 26: 309–313.
[19]
Shi WX, Chen SQ (2004) Frequencies of poor metabolizers of cytochrome P450 2C19 in esophagus cancer, stomach cancer, lung cancer and bladder cancer in Chinese population. World J Gastroenterol 10: 1961–1963.
[20]
Xie X, Ma YT, Fu ZY, Yang YN, Ma X, et al. (2011) Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population. Clin Chem Lab Med 49: 55–60.
[21]
Ashfield-Watt PA, Welch AA, Day NE, Bingham SA (2004) Is ‘five-a-day’ an effective way of increasing fruit and vegetable intakes? Public Health Nutr 7: 257–61.
[22]
Yang YN, Wang XL, Ma YT, Xie X, Fu ZY, et al. (2010) Association of interaction between smoking and CYP 2C19*3 polymorphism with coronary artery disease in a Uighur population. Clin Appl Thromb Hemost 16: 579–83.
[23]
Xie HG, Kim RB, Wood AJ, Stein CM (2001) Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol 41: 815–850.
